Add to ORKGThere is an urgent need to improve the evidence base for trauma care. Large-scale clinical trials can provide impor-tant answers, but they depend on effec-tive international collaboration. The purpose of this article is to bring one such trial, the CRASH-2 trial, to the attention of physicians around the world. The CRASH-2 trial, which is currently under way (registered at ISRCTN86750102), is a large placebo-controlled trial being performed in trauma patients at risk of significant haemorrhage. The trial examines the effects of antifibrinolytic treatment o
This paper reviews the application of tranexamic acid, an antifibrinolytic, to trauma. CRASH-2, a la...
Traumatic brain injury (TBI) is a major global concern and due to increased surveillance and recogni...
OBJECTIVES: To test the design and feasibility of a large scale multicentre randomised controlled tr...
This editorial is an open invitation to trauma doctors to participate in the international CRASH-2 t...
This article is an invitation to doctors around the world to participate in the CRASH-2 trial (Clini...
A large randomised placebo controlled trial among trauma patients with or at risk of significant hae...
Background: Tranexamic acid (TXA) has been shown to reduce blood loss in surgical patients and the r...
BACKGROUND: Tranexamic acid (TXA) has been shown to reduce blood loss in surgical patients and the r...
Eff ects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma pat...
The global epidemic of head injuries is just beginning. Many are caused by road traffic crashes. It ...
Copyright © 2015 Sophia Binz et al. This is an open access article distributed under the Creative Co...
Original article can be found at: http://www.informaworld.com/smpp/title~content=t713698281 Copyrigh...
Journal Article. This publication has been endorsed by the European Society of Anaesthesiology (ESA)...
This paper reviews the application of tranexamic acid, an antifibrinolytic, to trauma. CRASH-2, a la...
Traumatic brain injury (TBI) is an important public health problem, comparable to stroke in incidenc...
This paper reviews the application of tranexamic acid, an antifibrinolytic, to trauma. CRASH-2, a la...
Traumatic brain injury (TBI) is a major global concern and due to increased surveillance and recogni...
OBJECTIVES: To test the design and feasibility of a large scale multicentre randomised controlled tr...
This editorial is an open invitation to trauma doctors to participate in the international CRASH-2 t...
This article is an invitation to doctors around the world to participate in the CRASH-2 trial (Clini...
A large randomised placebo controlled trial among trauma patients with or at risk of significant hae...
Background: Tranexamic acid (TXA) has been shown to reduce blood loss in surgical patients and the r...
BACKGROUND: Tranexamic acid (TXA) has been shown to reduce blood loss in surgical patients and the r...
Eff ects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma pat...
The global epidemic of head injuries is just beginning. Many are caused by road traffic crashes. It ...
Copyright © 2015 Sophia Binz et al. This is an open access article distributed under the Creative Co...
Original article can be found at: http://www.informaworld.com/smpp/title~content=t713698281 Copyrigh...
Journal Article. This publication has been endorsed by the European Society of Anaesthesiology (ESA)...
This paper reviews the application of tranexamic acid, an antifibrinolytic, to trauma. CRASH-2, a la...
Traumatic brain injury (TBI) is an important public health problem, comparable to stroke in incidenc...
This paper reviews the application of tranexamic acid, an antifibrinolytic, to trauma. CRASH-2, a la...
Traumatic brain injury (TBI) is a major global concern and due to increased surveillance and recogni...
OBJECTIVES: To test the design and feasibility of a large scale multicentre randomised controlled tr...